These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17540575)

  • 21. Structure-activity relationship in a new series of atropine analogs. II. The effect of an asymmetric N-substituent on the antimuscarinic activity.
    Cherkez S; Yellin H; Kashman Y; Yaavetz B; Sokolovsky M
    Mol Pharmacol; 1978 Sep; 14(5):781-6. PubMed ID: 714023
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and evaluation of pharmacological activities of 3, 5-dialkyl 1, 4-dihydro-2,6-dimethyl-4-nitroimidazole-3, 5-pyridine dicarboxylates.
    Miri R; Javidnia K; Kebriaie-Zadeh A; Niknahad H; Shaygani N; Semnanian S; Shafiee A
    Arch Pharm (Weinheim); 2003 Sep; 336(9):422-8. PubMed ID: 14528490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural analysis and optimization of NK(1) receptor antagonists through modulation of atropisomer interconversion properties.
    Albert JS; Ohnmacht C; Bernstein PR; Rumsey WL; Aharony D; Alelyunas Y; Russell DJ; Potts W; Sherwood SA; Shen L; Dedinas RF; Palmer WE; Russell K
    J Med Chem; 2004 Jan; 47(3):519-29. PubMed ID: 14736234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solution-phase combinatorial synthesis of nonpeptide bradykinin antagonists.
    Kam YL; Rhee SJ; Choo HY
    Bioorg Med Chem; 2004 Jul; 12(13):3543-52. PubMed ID: 15186838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'.
    Shishido Y; Wakabayashi H; Koike H; Ueno N; Nukui S; Yamagishi T; Murata Y; Naganeo F; Mizutani M; Shimada K; Fujiwara Y; Sakakibara A; Suga O; Kusano R; Ueda S; Kanai Y; Tsuchiya M; Satake K
    Bioorg Med Chem; 2008 Aug; 16(15):7193-205. PubMed ID: 18640044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of alkyl 7,7-dihalo-3-methyl-5-(nitrophenyl)-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
    Mojarrad JS; Vo D; Velázquez C; Knaus EE
    Bioorg Med Chem; 2005 Jun; 13(12):4085-91. PubMed ID: 15911322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK(1) receptor antagonists: synthesis, antagonistic activity, and effects on bladder functions.
    Natsugari H; Ikeura Y; Kamo I; Ishimaru T; Ishichi Y; Fujishima A; Tanaka T; Kasahara F; Kawada M; Doi T
    J Med Chem; 1999 Sep; 42(19):3982-93. PubMed ID: 10508446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of peristalsis by NK3 receptor antagonism in guinea-pig isolated ileum is revealed as intraluminal pressure is raised.
    Sanger GJ; Tuladhar BR; Brown J; Aziz E; Sivakumar D; Furness JB
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):105-11. PubMed ID: 17391280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis by microwave irradiation and antidiarrhoeal activity of benzotriazinone and saccharine derivatives.
    Fiorino F; Caliendo G; Perissutti E; Severino B; Frecentese F; Preziosi B; Izzo AA; Capasso R; Santagada V
    Arch Pharm (Weinheim); 2005 Nov; 338(11):548-55. PubMed ID: 16281304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of spasmolytic activity of a fraction of Sarcostemma brevistigma Wight.
    Kumar PS; Soni K; Jadhav SR; Doshi NS; Saraf MN
    Indian J Exp Biol; 2007 May; 45(5):419-24. PubMed ID: 17569282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, QSAR and calcium channel modulator activity of new hexahydroquinoline derivatives containing nitroimidazole.
    Miri R; Javidnia K; Mirkhani H; Hemmateenejad B; Sepeher Z; Zalpour M; Behzad T; Khoshneviszadeh M; Edraki N; Mehdipour AR
    Chem Biol Drug Des; 2007 Oct; 70(4):329-36. PubMed ID: 17937778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective preparation of a cyclopentane-based NK1 receptor antagonist bearing an unsymmetrically substituted sec-sec ether.
    Kuethe JT; Marcoux JF; Wong A; Wu J; Hillier MC; Dormer PG; Davies IW; Hughes DL
    J Org Chem; 2006 Sep; 71(19):7378-90. PubMed ID: 16958533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a new series of potent and selective linear tachykinin NK2 receptor antagonists.
    Fedi V; Altamura M; Catalioto RM; Giannotti D; Giolitti A; Giuliani S; Guidi A; Harmat NJ; Lecci A; Meini S; Nannicini R; Pasqui F; Tramontana M; Triolo A; Maggi CA
    J Med Chem; 2007 Oct; 50(20):4793-807. PubMed ID: 17850056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nb-benzoyltryptamine derivatives with relaxant activity in guinea-pig ileum.
    Gutierrez SJ; de S Claudino F; Da Silva BA; Câmara CA; de Almeida RN; de Fátima V de Souza M; Da Silva MS; Da-Cunha EV; Barbosa-Filho JM
    Farmaco; 2005; 60(6-7):475-7. PubMed ID: 15913615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
    Leopoldo M; Lacivita E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Aug; 50(17):4214-21. PubMed ID: 17649988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthesis and bioactivity of substituted alpha-aminobenzylphosphonate].
    Zhao LZ; Yang RF; Zhao RS; Zhang YF; Chen DM; Wang H
    Yao Xue Xue Bao; 2006 Apr; 41(4):342-5. PubMed ID: 16856480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
    Di Fabio R; Griffante C; Alvaro G; Pentassuglia G; Pizzi DA; Donati D; Rossi T; Guercio G; Mattioli M; Cimarosti Z; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
    J Med Chem; 2009 May; 52(10):3238-47. PubMed ID: 19388677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Important roles of tachykinins in the development of allergic nasal hyperresponsiveness in guinea-pigs.
    Nabe T; Tsuzuike N; Ohtani Y; Mizutani N; Watanabe S; Fujii M; Yoshimura M; Nagasawa M; Kohno S
    Clin Exp Allergy; 2009 Jan; 39(1):138-46. PubMed ID: 18778270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.